In the press

Press releases & News

Lavie Bio Advances its Novel Bio-fungicide Program and Applies to the U.S. EPA for Regulatory Approval

LAV.311 is targeting fruit rots and powdery mildews fungal diseases Rehovot, Israel – October 12, 2022 — Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biological company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products, today announced submitting the registration package

Read more

Lavie Bio Announces Appointment of Guri Oron as CEO

Rehovot, Israel – September 14, 2022 — Lavie Bio Ltd. (“Lavie Bio”), a subsidiary of Evogene Ltd. (“Evogene”) (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biologicals company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products, today announced the appointment of Guri Oron as Chief Executive Officer (“CEO”) of

Read more

Lavie Bio Announces Successful Product Launch of its Bio-Inoculant result™ for the 2022 Spring Wheat Growing Season

Given wheat global shortages and high prices, Lavie foresees continued strong demand for its bio-inoculant result™ and plans increased production for 2023 growing season   Rehovot, Israel – May 11, 2022 — Lavie Bio Ltd., a subsidiary of Evogene Ltd., (NASDAQ: EVGN, TASE: EVGN) and a leading ag-biologicals company focusing on improving food quality, sustainability,

Read more

Lavie Bio Reports Advancement in its Bio-Fungicide Program for Fruit Rots

Advancement to the pre-commercial stage follows positive results from three consecutive years of vineyard trials for fruit rot diseases   Rehovot, Israel – December 14, 2021 – Lavie Bio Ltd., a leading ag-biologicals company focusing on improving food quality and agricultural productivity and sustainability through the introduction of microbiome-based products, and a subsidiary of Evogene

Read more